Citadel Advisors’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.3K Buy
+12,072
New +$22.8K ﹤0.01% 13612
2024
Q2
– Sell
-4,423
Closed -$29.4K – 14281
2024
Q1
$29.4K Buy
+4,423
New +$35.9K ﹤0.01% 12711
2023
Q3
– Sell
-5,470
Closed -$59.5K – 14305
2023
Q2
$59.5K Buy
5,470
+2,019
+59% +$23.9K ﹤0.01% 11603
2023
Q1
$51.6K Sell
3,451
-2,339
-40% -$50.4K ﹤0.01% 12101
2022
Q4
$155K Buy
5,790
+4,335
+298% +$125K ﹤0.01% 10564
2022
Q3
$46K Sell
1,455
-227
-13% -$5.88K ﹤0.01% 11685
2022
Q2
$39K Sell
1,682
-2,419
-59% -$69.1K ﹤0.01% 12073
2022
Q1
$147K Buy
+4,101
New +$136K ﹤0.01% 11869
2021
Q3
– Sell
-2,222
Closed -$73K – 13811
2021
Q2
$71K Buy
+2,222
New +$75.3K ﹤0.01% 13152
2019
Q2
– Sell
-1,406
Closed -$28K – 9176
2019
Q1
$28K Buy
+1,406
New +$27.4K ﹤0.01% 9008

Other funds holding BMRA

Citadel Advisors's BMRA Position: Q3 2026 in Review

Citadel Advisors opened a new position in Biomerica (BMRA) in Q3 2026: 12,072 shares worth $27.3K. The stake represents ﹤0.01% of the portfolio and ranks #13612 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BMRA as recently as Q1 2024.

Citadel Advisors first reported a position in BMRA in Q1 2019 and has held it in 10 quarters since. The position peaked at $155K in Q4 2022. 21 funds tracked by Wall St. Rank hold BMRA as of Q3 2026.

  • Citadel Advisors held 12,072 shares of Biomerica worth $27.3K as of Q3 2026.
  • Biomerica was a new Citadel Advisors position in Q3 2026.
  • Biomerica made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13612 holding.
  • Citadel Advisors first reported a position in Biomerica in Q1 2019 and has held it in 10 quarters since.
  • Citadel Advisors's Biomerica position peaked at $155K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held Biomerica as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.